Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,356 | 36,399 | 42,739 | 115,077 | 34,814 |
| Marketable Securities | 696,925 | 719,600 | 759,578 | 708,769 | 388,784 |
| Receivables | 700 | 852 | 1,534 | 2,671 | 2,628 |
| TOTAL | $747,159 | $778,842 | $811,975 | $835,324 | $431,693 |
| Non-Current Assets | |||||
| PPE Net | 4,346 | 4,230 | 3,864 | 4,061 | 4,060 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 13,645 | 12,917 | 2,557 | 2,272 | 2,684 |
| TOTAL | $45,181 | $44,337 | $33,611 | $33,523 | $33,934 |
| Total Assets | $792,340 | $823,179 | $845,586 | $868,847 | $465,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 942 | N/A | N/A | N/A | 3,988 |
| Accounts payable and accrued liabilities | 3,265 | 1,114 | 3,802 | 3,234 | 3,494 |
| Accrued Expenses | 33,842 | 28,204 | 18,594 | 17,536 | 22,029 |
| Other current liabilities | N/A | 1,396 | 3,673 | 3,877 | N/A |
| TOTAL | $39,501 | $32,093 | $27,658 | $26,291 | $31,125 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,834 | 5,181 | 4,269 | 3,943 | 5,331 |
| TOTAL | $5,834 | $5,181 | $4,269 | $3,943 | $5,331 |
| Total Liabilities | $45,335 | $37,274 | $31,927 | $30,234 | $36,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,384 | 66,344 | 66,288 | 65,911 | 55,901 |
| Common Shares | 66 | 66 | 66 | 66 | 56 |
| Retained earnings | -1,555,224 | -1,508,132 | -1,466,011 | -1,430,169 | -1,397,361 |
| Other shareholders' equity | 3,314 | 5,288 | 1,780 | 2,244 | 3,308 |
| TOTAL | $747,005 | $785,905 | $813,659 | $838,613 | $429,171 |
| Total Liabilities And Equity | $792,340 | $823,179 | $845,586 | $868,847 | $465,627 |